Clin2
NCT06692361Possibly a fitRecruiting

Gut bacteria transplant for depression not helped by escitalopram

Major Depressive Disorder (MDD)Depression - Major Depressive Disorder

Treatments studied

Part of Mental health clinical trials.

This trial tests whether transplanting healthy gut bacteria (fecal microbiota) can help people with depression that does not respond well to the antidepressant escitalopram. You will first take escitalopram for 2 weeks, and if it doesn't help enough, you may receive either the real transplant or a placebo capsule.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
214 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are between 18 and 65 years old.
  • You have been diagnosed with major depression (recurrent or a single episode).
  • You are not currently taking any antidepressant for this episode.
  • You are willing to start the antidepressant escitalopram (Lexapro).
  • Your depression does not improve enough after 2 weeks of escitalopram (less than 20% reduction in symptoms).
  • You are able to swallow capsules and have no serious gut problems or recent antibiotic use.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07480525Recruiting
Escitalopram for first-time depression

This trial tests whether escitalopram, a common antidepressant, helps people who are experiencing their first episode of depression and have never taken medication for it. It also looks at how the drug works in the brain.

Beijing, Beijing Municipality
NCT05850572Not yet recruiting
Fecal transplant study for depression

This trial tests whether fecal microbiota transplantation (FMT, a stool-based treatment that changes gut bacteria) can improve symptoms of first-episode depression. It’s mainly for adults with moderate-to-severe depression based on a common symptom score.

NCT06297421Not yet recruiting· Phase 2
Fecal transplant for IBS with diarrhea and anxiety or depression

This trial tests if a fecal microbiota transplant (FMT) can help young adults with irritable bowel syndrome with diarrhea (IBS-D) who also have symptoms of anxiety or depression. FMT involves putting processed stool from a healthy donor into your gut to improve digestive and mental health at the same time.

Shenzhen, Guangdong
NCT07331987Recruiting
Probiotics for mild to moderate anxiety or depression study

This trial tests if probiotics can help reduce symptoms of mild to moderate anxiety or depression. It is for people aged 18–60 who are not currently taking most anxiety or depression medications and who have not used them in the last 2 weeks (except for escitalopram).

Guangzhou, Guangdong
NCT07481422Recruiting· Phase 1/Phase 2
Fecal transplant capsules for irritable bowel syndrome

This trial tests whether taking capsules containing freeze-dried healthy donor stool can improve symptoms of irritable bowel syndrome (IBS) that haven't gotten better with usual treatments. It aims to see if this approach is safe and helpful for people with moderate to severe IBS.

Rijeka
NCT05850585Not yet recruiting
Fecal transplant study for people with schizophrenia

This trial studies whether fecal microbiota transplantation (a procedure that transfers gut bacteria) can improve symptoms in people with schizophrenia. It may help by changing the gut microbiome, which researchers think could affect brain and behavior symptoms.

Hear when a new Depression - Major Depressive Disorder trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.